Purpose: To determine the efficacy of using a human amniotic membrane to close macular hole retinal detachment in highly myopic eyes. Study design: Prospective, consecutive, nonrandomized interventional study. Methods: We included 19 high myopic eyes from 19 patients affected by macular hole retinal detachment who had already undergone vitrectomy with internal limiting membrane peeling. The patients underwent vitrectomy with amniotic membrane transplant. Results: Primary success was achieved after 3 months in 89.5% (17 of 19 eyes) and final macular hole closure was obtained in 94.7% (18 of 19 eyes) of the patients. The final retinal reattachment rate was 100%. The final 12-month mean BCVA improved from 20/2000 (2 logMAR) to 20/250 (1.1 logMAR). OCT-angiography revealed a high correlation between the superficial and deep capillary plexus and the final BCVA. Conclusion: Human amniotic membrane patches can effectively repair macular hole retinal detachment in high myopic eyes in terms of anatomic results and BCVA recovery.
Treatment of recurrent high myopic macular hole associated with retinal detachment using a human amniotic membrane / Tomaso Caporossi , Lorenzo Governatori , Gloria Gambini , Antonio Baldascino , Umberto De Vico , Matteo Ripa , Alessandra Scampoli , Matteo Mario Carlà , Clara Rizzo , Raphael Kilian , Stanislao Rizzo. - In: JAPANESE JOURNAL OF OPHTHALMOLOGY. - ISSN 0021-5155. - ELETTRONICO. - (2022), pp. 0-0. [10.1007/s10384-022-00953-w]
Treatment of recurrent high myopic macular hole associated with retinal detachment using a human amniotic membrane
Tomaso Caporossi;Lorenzo Governatori;Clara Rizzo;Stanislao Rizzo
2022
Abstract
Purpose: To determine the efficacy of using a human amniotic membrane to close macular hole retinal detachment in highly myopic eyes. Study design: Prospective, consecutive, nonrandomized interventional study. Methods: We included 19 high myopic eyes from 19 patients affected by macular hole retinal detachment who had already undergone vitrectomy with internal limiting membrane peeling. The patients underwent vitrectomy with amniotic membrane transplant. Results: Primary success was achieved after 3 months in 89.5% (17 of 19 eyes) and final macular hole closure was obtained in 94.7% (18 of 19 eyes) of the patients. The final retinal reattachment rate was 100%. The final 12-month mean BCVA improved from 20/2000 (2 logMAR) to 20/250 (1.1 logMAR). OCT-angiography revealed a high correlation between the superficial and deep capillary plexus and the final BCVA. Conclusion: Human amniotic membrane patches can effectively repair macular hole retinal detachment in high myopic eyes in terms of anatomic results and BCVA recovery.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
